Evid Invest
Who owns TVTXWhat TVTX owns — n/a

Who owns Travere Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of TVTX from SEC Form 13F filings across 345 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 345 institutions disclosed 110.5M shares of Travere Therapeutics, Inc. worth $6.51B — about 116.8% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.

345

13F holders

$6.51B

value, 2026 filers

116.8%

of shares outstanding (110.5M sh)

63

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TVTX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Janus Henderson Group Ltd.NEW11.9M$700.1M0.3%12.6%new
2BlackRock, Inc.8.7M$510.7M0.0%9.2%+8.1%
3FMR LLC5.9M$345.5M0.0%6.2%-17.3%
4BANK OF AMERICA CORP /DE/5.8M$342.9M0.0%6.2%+27.5%
5STATE STREET CORP4.4M$258.3M0.0%4.6%+3.1%
6VANGUARD CAPITAL MANAGEMENT LLC4.2M$246.9M0.0%4.4%+2.0%
7PERCEPTIVE ADVISORS LLC3.5M$208.6M3.6%3.7%-5.6%
8VANGUARD PORTFOLIO MANAGEMENT LLC3.0M$179.0M0.0%3.2%+97.2%
9GEODE CAPITAL MANAGEMENT, LLC2.4M$142.5M0.0%2.6%+2.0%
10ADAGE CAPITAL PARTNERS GP, L.L.C.2.4M$141.9M0.2%2.5%-6.2%
11NOMURA ASSET MANAGEMENT INTERNATIONAL INC.2.2M$131.9M0.1%2.4%-20.4%
12Rock Springs Capital Management LP2.2M$129.8M7.0%2.3%+1.1%
13Kynam Capital Management, LP2.0M$117.8M6.5%2.1%0.0%
14PRICE T ROWE ASSOCIATES INC /MD/1.9M$110.8M0.0%2%+42.7%
15Stephens Investment Management Group LLC1.9M$110.5M1.2%2%+0.1%
16GOLDMAN SACHS GROUP INC1.8M$106.4M0.0%1.9%+17.7%
17WELLINGTON MANAGEMENT GROUP LLP1.6M$93.0M0.0%1.7%+3.0%
18EMERALD ADVISERS, LLC1.6M$92.1M2.5%1.7%-2.3%
19Driehaus Capital Management LLC1.5M$90.3M0.6%1.6%+6.5%
20ARMISTICE CAPITAL, LLC1.3M$75.9M0.9%1.4%-18.0%
21ORBIMED ADVISORS LLC1.2M$70.7M1.3%1.3%+374.5%
22Qube Research & Technologies Ltd1.2M$69.0M0.1%1.2%-18.8%
23Assenagon Asset Management S.A.1.1M$67.4M0.1%1.2%+168.1%
24MPM BIOIMPACT LLC1.1M$64.1M4.8%1.2%-3.1%
25RENAISSANCE TECHNOLOGIES LLC1.1M$63.5M0.1%1.1%-41.2%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.